Oncology & Cancer

New pharmacon allows testicular tumors to shrink

Testicular cancer is the most common malignant tumor disease in men between 20 and 40 years of age. It can usually be treated well. In some cases, however, the cancer hardly responds or does not respond at all to treatment. ...

Genetics

New finding reveals battle behind gene expression

The complex process regulating gene expression is often compared to following a recipe. Miss a genetic ingredient, or add it in the wrong order, and you could have a disaster on your hands.

Oncology & Cancer

SCCM: circulating histones for most with thrombocytopenia

(HealthDay)—Most patients with thrombocytopenia have circulating histones, according to a research letter published online Feb. 22 in the Journal of the American Medical Association to coincide with the Society of Critical ...

page 8 from 14